Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716
Carl D. Richards(McMaster University Medical Centre), John F. Paolini(Synta Pharmaceuticals (United States))
Cited by 21
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
|European Heart Journal|2011|614
The Enigmatic Cytokine Oncostatin M and Roles in Disease
|ISRN Inflammation|2013|205
Leukocyte recruitment and expression of chemokines following different forms of vascular injury
|Vascular Medicine|2003|79
Oncostatin-M Up-Regulates VCAM-1 and Synergizes with IL-4 in Eotaxin Expression: Involvement of STAT6
|The Journal of Immunology|2006|44